Aradhana Sasan

Array ( [id] => 5336852 [patent_doc_number] => 20090053316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'NANOCLUSTERS FOR DELIVERY OF THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/261907 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13771 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053316.pdf [firstpage_image] =>[orig_patent_app_number] => 12261907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330239 [patent_doc_number] => 20090110716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'ORALLY DISINTEGRATIVE DOSAGE FORM' [patent_app_type] => utility [patent_app_number] => 12/260151 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8123 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110716.pdf [firstpage_image] =>[orig_patent_app_number] => 12260151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8542905 [patent_doc_number] => 08318191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Porous material having hierarchical porous structure and preparation method thereof' [patent_app_type] => utility [patent_app_number] => 12/253054 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5762 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12253054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353761 [patent_doc_number] => 20100086601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Modified Calcium Phosphate Nanoparticle Formation' [patent_app_type] => utility [patent_app_number] => 12/245450 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3934 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086601.pdf [firstpage_image] =>[orig_patent_app_number] => 12245450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495403 [patent_doc_number] => 20090263431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'POLYURETHANE FOAMS FOR WOUND MANAGEMENT' [patent_app_type] => utility [patent_app_number] => 12/244313 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10463 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263431.pdf [firstpage_image] =>[orig_patent_app_number] => 12244313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446090 [patent_doc_number] => 20090047316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Porous particles loaded with cosmetically or pharmaceutically active compounds' [patent_app_type] => utility [patent_app_number] => 12/285297 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5919 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047316.pdf [firstpage_image] =>[orig_patent_app_number] => 12285297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392798 [patent_doc_number] => 20100303916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'ENHANCED DRUG DELIVERY WITH ORIENTABLE PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/678105 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7943 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303916.pdf [firstpage_image] =>[orig_patent_app_number] => 12678105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533097 [patent_doc_number] => 20090232885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids' [patent_app_type] => utility [patent_app_number] => 12/209285 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12314 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232885.pdf [firstpage_image] =>[orig_patent_app_number] => 12209285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11547202 [patent_doc_number] => 09616026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Sustained release formulations of sotalol' [patent_app_type] => utility [patent_app_number] => 12/231896 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11272 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12231896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839453 [patent_doc_number] => 20080279938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'ZALTOPROFEN-CONTAINING SUSTAINED RELEASE TABLET AND PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/181112 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4712 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279938.pdf [firstpage_image] =>[orig_patent_app_number] => 12181112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949039 [patent_doc_number] => 20080305165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'SUSTAINED RELEASE ORAL FORMULATION AND PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/181038 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6094 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305165.pdf [firstpage_image] =>[orig_patent_app_number] => 12181038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320817 [patent_doc_number] => 20100196429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Oil-In-Water Emulsion Composition And Method For Producing The Same' [patent_app_type] => utility [patent_app_number] => 12/670895 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8854 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196429.pdf [firstpage_image] =>[orig_patent_app_number] => 12670895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992646 [patent_doc_number] => 20110014299 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2011-01-20 [patent_title] => 'SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/452705 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0014/20110014299.pdf [firstpage_image] =>[orig_patent_app_number] => 12452705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992646 [patent_doc_number] => 20110014299 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2011-01-20 [patent_title] => 'SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/452705 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0014/20110014299.pdf [firstpage_image] =>[orig_patent_app_number] => 12452705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310226 [patent_doc_number] => 20090017507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'DRY GRANULATED PRODUCT CONTAINING L-LYSINE AS MAIN COMPONENT' [patent_app_type] => utility [patent_app_number] => 12/172676 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8081 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017507.pdf [firstpage_image] =>[orig_patent_app_number] => 12172676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617863 [patent_doc_number] => 20100003322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'ENTERIC COATED HYDROPHOBIC MATRIX FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/167876 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7397 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003322.pdf [firstpage_image] =>[orig_patent_app_number] => 12167876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296091 [patent_doc_number] => 20090011017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'POLYMERS BASED ON WATER-SOLUBLE MONOOLEFINIC COMPRISING COLLOIDAL SILICA AND THEIR USE AS MATRIX POLYMERS FOR SOLID DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 12/164246 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2390 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011017.pdf [firstpage_image] =>[orig_patent_app_number] => 12164246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280712 [patent_doc_number] => 20100119566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'USE OF A SYNERGISTIC COMPOSITIONS AS A THERAPEUTIC AGENT OR DISINFECTANT' [patent_app_type] => utility [patent_app_number] => 12/452295 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5495 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119566.pdf [firstpage_image] =>[orig_patent_app_number] => 12452295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852116 [patent_doc_number] => 20080317858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'FORMULATIONS OF N-(2-ACETYL-4,6-DIMETHYLPHENYL)-3--2-THIOPHENECARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 12/145452 [patent_app_country] => US [patent_app_date] => 2008-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14777 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317858.pdf [firstpage_image] =>[orig_patent_app_number] => 12145452 [rel_patent_id] =>[rel_patent_doc_number] =>)